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Chronic inflammation contributes to tumor initiation in colitis-associated colorectal 
cancer (CRC). Indeed, inflammatory bowel disease (IBD) patients show an increased 
risk of developing CRC. Cancer immune evasion is a major issue in CRC and preclinical 
and clinical evidence has defined a critical role for myeloid-derived suppressor cells 
(MDSCs) that contribute to tumor growth and progression by suppressing T-cells and 
modulating innate immune responses. MDSCs comprise a heterogeneous population 
of immature myeloid cells that can be distinct in two subtypes: CD11b+Ly6G+Ly6Clow 
with granulocytic phenotype (G-MDSCs) and CD11b+Ly6G−Ly6Chigh with monocytic 
phenotype (M-MDSCs). Hydrogen sulfide (H2S) is an endogenous gaseous signaling 
molecule that regulates various physiological and pathophysiological functions. In par-
ticular, several studies support its anti-inflammatory activity in experimental colitis and 
ulcer. However, the role of the H2S pathway in innate immune-mediated IBD has not yet 
been elucidated. To better define a possible link between MDSCs and H2S pathway in 
colitis-associated CRC development, we used an innate immune-mediated IBD model 
induced by infection with the bacterium Helicobacter hepaticus (Hh), closely resembling 
human IBD. Here, we demonstrated an involvement of MDSCs in colitis development. 
A significant time-dependent increase of both G-MDSCs and M-MDSCs was observed 
in the colon and in the spleen of Hh-infected mice. Following, we observed that chronic 
oral administration of the H2S donor DATS reduced colon inflammation by limiting the 
recruitment of G-MDSCs in the colon of Hh-infected mice. Thus, we identify the metabolic 
pathway l-cysteine/H2S as a possible new player in the immunosuppressive mechanism 
responsible for the MDSCs-promoted colitis-associated cancer development.
Keywords: colitis-associated cancer, colorectal cancer, cystathionine gamma-lyase, cystathionine beta-synthase, 
Helicobacter hepaticus, hydrogen sulfide, myeloid-derived suppressor cells
inTrODUcTiOn
Colorectal cancer (CRC) is one of the major cause of morbidity and mortality throughout the world. 
It is the third most common cancer worldwide1. Chronic intestinal inflammation is the primary 
risk factor for the development of gastrointestinal malignancy (1). A meta-analysis estimates 
the risk of CRC in ulcerative colitis patients to be 2% after 10 years, 8% after 20 years, and 18% 
1 Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=colorectal (Accessed: October 25, 2017)
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after 30 years of disease (2). Although the exact etiology remains 
unclear, a multifactorial interaction among immunological, 
genetic, and environmental factors contribute to the disturbance 
of homeostasis leading to the generation of an abnormal immune 
response against the commensal microbiota (3, 4). In particular, 
loss of the intestinal homeostasis and induction of pathogenic 
inflammatory response is first related to the aberrant activation 
of the innate immune system in the gut that consists of intestinal 
epithelial cells and several leukocyte population (i.e., neutrophils, 
dendritic cells, monocytes/macrophages, and innate lymphoid 
cells) (5). Cancer immune evasion is a major issue in CRC 
and preclinical and clinical evidence has defined a critical role 
for myeloid-derived suppressor cells (MDSCs) in modulating 
the innate immune responses by suppressing T cell anti-tumor 
functions (6). MDSCs consist of a heterogeneous population 
of immature myeloid cells characterized by co-expression of 
CD11b and Gr-1 (7). Two distinct subtypes of MDSCs have been 
identified in tumor-bearing mice: CD11b+Ly6G+Ly6Clow with 
granulocytic phenotype (G-MDSCs) and CD11b+Ly6G−Ly6Chigh 
with monocytic phenotype (M-MDSCs). Both M-MDSCs and 
G-MDSCs exercise their potent immunosuppressive activity by 
modifying the microenvironment through the depletion of amino 
acids (arginine, tryptophan, glutamine, and cysteine). So far, the 
main immunosuppressive mechanisms described are based on 
l-arginine metabolism via Arginase 1 (ARG1) and inducible nitric 
oxide synthase 2 (NOS2) and reactive oxygen species production 
(8–10). In CRC, the blood MDSCs numbers correlate with stage 
and metastatic burden (11). Similar G-MDSCs and M-MDSCs 
populations have also been described in inflammatory bowel 
diseases (IBD). However, their role in both IBD and CRC still 
needs to be elucidated (12).
Helicobacter species that colonize the lower bowel and biliary 
tract of mice have been associated with the development of 
colitis resembling human IBD in susceptible hosts. Furthermore, 
Helicobacter hepaticus (Hh) infection has been demonstrated 
to exacerbate the development of cancer at both intestinal and 
extra-intestinal sites (13). To better define the role of MDSCs in 
colitis development, we used an innate immune-mediated IBD 
model induced by infection with Hh. Epithelial hyperplasia and 
crypt abscesses, associated with a marked granulocyte accumula-
tion within intestinal tissues, characterize this preclinical model 
closely resembling the human IBD (14). Hh is a gram-negative, 
spiral-shaped, microaerophilic bacterium that is a common 
member of the mouse intestinal microbiota found predominantly 
in the cecum and colon. Although it does not cause invasive 
infections in most immune competent mouse strains, Hh induces 
chronic intestinal inflammation in susceptible mice lacking 
adaptive immune system, such as 129SvEvRag−/− mice, that can 
eventually progress to colon cancer (13).
Recently, it has been demonstrated that hydrogen sulfide 
(H2S) promotes the resolution of colitis and enhance ulcer heal-
ing (15, 16). H2S is an endogenous gaseous signaling molecule 
that regulates various physiological and pathophysiological 
functions. In particular, H2S exhibits several anti-inflammatory 
effects such as reduction of edema formation and suppression 
of pro-inflammatory cytokines release (17). In mammals, H2S 
is endogenously produced from sulfur-containing amino acids, 
such as l-cysteine (l-cys), mainly by two pyridoxal-5′-phosphate 
(P5P)-dependent enzymes, cystathionine gamma-lyase (CSE, EC 
4.4.1.1), and cystathionine beta-synthase (CBS, EC4.2.1.22). H2S 
is also generated from dietary sulfate metabolism in the lumen 
of the large intestine by anaerobic sulfate-reducing bacteria 
(18). The role of H2S colonic inflammation and cancer has been 
recently reviewed (18–20). However, the role of hydrogen sulfide 
pathway in innate immune-mediated IBD has not yet been elu-
cidated. Here, we have evaluated the role of MDSCs and its link 
with the hydrogen sulfide pathway in the intestinal inflammation 
development upon stimulation with pathogenic Hh.
MaTerials anD MeThODs
animals
129SvEvRag2−/− (Rag2−/−) mice were bred and maintained 
under specific pathogen-free conditions in an accredited animal 
facility in the Pathology Services Building at the University of 
Oxford. Experiments were conducted in accordance with the 
UK Scientific Procedures Act (1986) under a Project License 
(PPL) authorized by the UK Home Office Animal Procedures 
Committee and approved by the Sir William Dunn School Ethical 
Review Committee.
induction of colitis
Helicobacter hepaticus NCI-Frederick isolate 1A (strain 51449) 
was grown on blood agar plates containing trimethoprim, van-
comycin, and polymyxin B under microaerophilic conditions. 
Cultures were expanded for 3–4 days in TSB (Oxoid) containing 
10% FCS (GIBCO BRL) and Helicobacter-free Rag2−/− mice were 
fed three times on consecutive days with Hh 1A (1.0 × 108 CFU) 
by oral gavage. Mice were sacrificed at different time points (3 and 
6 weeks) after the first Hh inoculation.
In Vivo Drug Treatment
Helicobacter hepaticus-infected Rag2−/− mice received diallyl 
trisulfide (DATS; 50 mg/kg) or vehicle (PBS) starting at week 4 
after the first Hh inoculation. DATS or vehicle were given by oral 
gavage once a day for 14 days. Treatment groups were mixed in 
cages to minimize cage effects.
assessment of intestinal inflammation
Mice were sacrificed when symptoms of clinical disease (diarrhea) 
became apparent in control groups, usually 6 weeks after initiation 
of experiments. Samples of proximal, mid, and distal colon were 
immediately fixed in buffered 10% formalin. Four to five microns 
of paraffin-embedded sections were stained with hematoxylin 
and eosin, and inflammation was graded according to the follow-
ing scoring system. Each sample was graded semi-quantitatively 
from 0 to 3 for four criteria: (1) degree of epithelial hyperplasia 
and goblet cell depletion; (2) leukocyte infiltration in the lamina 
propria; (3) area of tissue affected; (4) presence of markers of 
severe inflammation such as crypt abscesses, submucosal inflam-
mation, and ulcers. Typical features of each grade are as follows: 
0 =  normal; 1 =  mild epithelial hyperplasia; 2 =  pronounced 
hyperplasia with substantial leukocytic infiltrates; 3  =  severe 
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hyperplasia severe transmural inflammation, ulceration, crypt 
abscesses, and severe depletion of goblet cells. Scores for each 
criterion were added to give an overall inflammation score for 
each sample of 0–12. The individual scores from the section of 
proximal, mid, and distal colon were averaged to obtain the total 
inflammation scores for the colon.
isolation of leukocyte subpopulations 
from spleen and colon
Cell suspensions from spleen and colon from infected and unin-
fected Rag2−/− mice were prepared as described below. Colons were 
longitudinally opened, cut into 1-cm pieces, and incubated (three 
times) in RPMI 1640 with 10% FCS and 5 mM EDTA at 37°C to 
remove epithelial cells. Tissue was then digested with collagenase 
VIII/DNase I solution for 45 min at 37°C. The isolated cells were 
layered on a 30/40/75% Percoll gradient, which was centrifuged 
for 20 min at 600 g, and the 40/75% interface, containing mostly 
leukocytes, was recovered. Spleens were crushed in petri dish on 
filter with syringe. The cells were collected and suspended in ACK 
for the lysis of red blood cells and then centrifuge at 1,500 rpm for 
5 min. Cells were then analyzed using flow cytometry.
Flow cytometry
Aliquots of 5  ×  105 cells were washed in FACS buffer (PBS, 
0.1% BSA), incubated with a fixable viability dye and anti-Fc 
receptor (αCD16/32), and stained using the following panel of 
monoclonal antibodies to murine cell surface molecules (all 
from BD Biosciences): PerCP-Cy5.5-conjugated anti-CD11b, 
PE-conjugated anti-Ly6G, FITC-conjugated anti-Ly6C, and 
Violet1-conjugated anti-CD45. Cells were washed in FACS buffer 
and analyzed by Dako Cyan Flow cytometry.
h2s synthesizing activity in colon
Samples from colon of 1  cm from infected and uninfected 
Rag2−/− mice were taken from the proximal, mid, and distal 
region, snap frozen in liquid nitrogen and stored at −80°C until 
the H2S assay was performed. Colon pieces were homogenized 
in ice-cold 100 mmol/L potassium phosphate buffer (pH = 7.4), 
sodium orthovanadate 10  mM, PMSF 100  mM, and protease 
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA) with 
a FastPrep™24 homogenizer, and the protein concentration 
was determined using the Bradford assay. H2S synthesis from 
colon tissue homogenates was measured in the presence of the 
exogenous substrate l-cys and the cofactor required by H2S-
producing enzymes, P5P and in the presence of the CSE inhibitor 
(dl-propargylglycine; PAG) or CBS inhibitor (O-carboxymethyl-
hydroxylamine hemihydrochloride, CHH). The lysates were 
added in a reaction mixture (total volume 500  µL) containing 
P5P (2 mM, 20 µL), l-cys (10 mM, 20 µL), and saline (30 µL) or 
P5P (2 mM, 20 µL), L-cys (2 mM, 20 µL), and CHH/PAG (30 µL). 
The reaction was performed in parafilm-sealed Eppendorf tubes 
and initiated by transferring tubes from ice to a 37°C water bath. 
After 40  min incubation, zinc acetate 1% (ZnAc; 250  µL) was 
added to trap any H2S emitted followed by trichloroacetic acid 
10% (TCA; 250  µL). Subsequently, N,N-dimethylphenylendia
mminesulphate 20 µM (DPD; 133 µL) in 7.2 M HCl and FeCl3 
(30 µM, 133 µL) in 1.2 M HCl were added. After 20 min, absorb-
ance values was measured at 670 nm with a microplate reader 
and H2S concentration was calculated against a calibration curve 
of NaHS (3.12–250 µM). Results are expressed as nanomoles per 
milligram protein per minute.
immunoblot
Cystathionine beta-synthase and CSE intestinal levels was 
performed by Western blot analysis of colonic tissues of either 
healthy mice or mice 6 weeks following the induction of colitis. 
Tissue homogenates were obtained as described above. Equal 
amounts of protein (40 µg) were loaded onto a 10% gel, subjected 
to SDS-PAGE, and electro-transferred onto polyvinylidene 
difluoride (PVDF) membranes (Hybond-P PVDF Membrane, 
Amersham Biosciences, Buckinghamshire, UK). The membranes 
were blocked for 2 h in 5% low-fat milk in PBS with 0.1% Tween 
20 (PBST) at room temperature. Then, the filters were incubated 
with the following primary antibodies: CSE (1:500 dilution, 
Proteintech), CBS (1:500, Novus Biological), and GAPDH 
(1:1,000 dilution, Santa Cruz Biotechnology) overnight at 4°C. 
The membranes were washed three times with PBST and then 
incubated with HRP-conjugated anti-mouse or anti-rabbit IgG 
(1:2,000, Cell Signaling) for 2 h at room temperature. The immune 
complexes were detected by the ECL chemiluminescence method 
(Thermo Fisher Scientific).
rna Purification and Quantitative  
real-Time Pcr
Colon samples were snap frozen in liquid nitrogen. Tissue 
material was homogenized in RLT buffer (QIAGEN) with 
β-mercaptoethanol using FastPrep™24 homogenizer (MP 
Biomedicals) with lysing matrix D beads (MP Biomedicals). RNA 
isolation was performed using the RNeasy kit (QIAGEN). RNA 
purity and quantification was determined using a Nanodrop spec-
trophotometer (Thermo Fisher Scientific). cDNA synthesis was 
performed using the Superscript III reverse transcription kit from 
Invitrogen. Quantitative real-time PCR for the candidate genes 
was carried out as described before (21) using the following primer 
pairs: CBS isoform 1: 5′-CCAGGCACCTGTGGTCAAC-3′ and 
3′-GGTCTCGTATTGGATCTGCT-5′; CSE: 5′-TTCCTGCCTA 
GTTTCCAGCAT-3′, and 3′-GGAAGTCCTGCTTAAATGTGG 
TG-5′; IL-6: 5′-GAGGATACCACTCCCAACAGACC-3′ and 3′-AA 
GTGCATCATCGTTGTTCATACA-5′; TNF-α: 5′-TACTGAACT 
TCGGGGTGATTGGTCC-3′ and 3′-CCTGGTTAGTGGGGCT 
TCAAGTCAT-5′. Primers for Hprt (Mm01545399_m1), was 
obtained from Applied Biosystems. cDNA samples were analyzed 
in triplicate and values were normalized on Hprt expression. 
Analysis was performed according to the ∆−Ct method.
Quantification of Hh in cecal contents
DNA was purified from cecal content taken from Hh-infected 
mice using the DNA Stool kit (QIAGEN). Hh DNA was quantified 
using a real-time PCR method based on the cdtB gene, performed 
with the ABI prism Taqman 7700 sequence detection system (PE 
Biosystems). Standard curves were constructed using Hh DNA 
that was purified from bacterial cultures using the DNeasy kit 
(QIAGEN).
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In Vitro stimulation of Bone Marrow-
Derived Macrophages (BMDMs)
Bone marrow cells were isolated from femur and tibia of C57/
BL6 mice and were cultured in L929 fibroblast conditioned RPMI 
1640 medium (containing 15% L929 supernatant and 10% FCS) 
for 7  days. The resulting macrophages were stimulated over 
night with 20 MOI of live Hh. Cells were pre-incubated with 
DATS (10 µM) 30 min before the stimulation with Hh. Then, the 
supernatants were collected for the detection of IL-6 and TNFα 
cytokines by ELISA.
elisa
IL-6 and TNFα levels in culture supernatants were evaluated 
using ELISA kits according to the manufacturer’s instruction 
(DuoSet ELISA, R&D systems, Minneapolis, MN, USA).
statistical analysis
Values were expressed as mean  ±  SEM. Differences between 
experimental groups were assessed by Student’s t-test or one-way 
ANOVA, followed by Bonferroni test P <  0.05 was considered 
statistically significant: *P < 0.05; **P < 0.01; ***P < 0.001.
resUlTs
MDscs accumulate in spleen and in 
colon of Hh-infected Mice
T cell- and B cell-deficient Rag2−/− mice were infected with Hh. 
As early as 3–6 weeks after Hh infection, mice developed sple-
nomegaly and severe intestinal inflammation (Figures  1A,B). 
The response was dependent upon the activation of the innate 
immunity and characterized by a marked epithelial cell hyperpla-
sia, extensive inflammatory infiltrates, and goblet cell depletion. 
Hh infection of Rag2−/− mice resulted in a profound proliferation 
of both splenic and intestinal leukocytes as previously shown 
(14) (data not shown). To verify the presence of MDSCs in the 
splenic and colon lamina propria lymphoid immune population, 
we performed a FACS staining for the two MDSCs subpopulation 
based on differential expression of Ly6C and Ly6G (Figure 1C). 
In fact, as previously described (9), the mononuclear fraction 
(M-MDSCs) is characterized by CD11b+Ly6G−Ly6Chigh pheno-
type and the polimorfononuclear fraction (G-MDSCs) is char-
acterized by CD11b+Ly6G+Ly6Clow phenotype. The progressive 
intestinal inflammation induced by Hh in Rag2−/− mice induced a 
significant (P < 0.001), time-dependent increase in the frequency 
of each fractions both in colon (Figures 1D,E) and spleen lym-
phoid immune populations (Figures  1F,G). Three weeks after 
infection, a marked expansion of both G-MDSCs and M-MDSCs 
was observed. Conversely, after 3 weeks more (at 6 weeks), only 
the G-MDSC populations resulted increased by about 20%, 
whereas M-MDSCs remained almost unchanged. These results 
suggest that the polimorfonuclear fraction might have a pivotal 
role in colitis development in this inflammatory setting.
colonic h2s synthesis is Markedly 
reduced after Hh infection
Both CBS and CSE are constitutively expressed in the 
colon of healthy Rag2−/− mice with no significant difference 
between CBS/CSE protein (Figure  2A) and gene expression 
(Figure 2B). Thus, we evaluated the metabolic activity of these 
enzymes by measuring their ability to produce sulfide adding 
the substrate l-cys and their respective inhibitors. In healthy 
mice, we found that the preferential CBS inhibitor CHH 
(3 mmol/L) reduced H2S synthesis by ~65% (P < 0.001, vs. l-
cys), whereas the selective CSE inhibitor PAG (10 mmol/L) was 
ineffective (Figure 2C). These results imply that in the colon 
of Rag2−/− mice: (i) CBS appears to be the major responsible 
for colonic H2S synthesis and (ii) change in the CBS activity 
accounts for H2S production. After 3 and 6  weeks following 
Hh mouse infection, we observed a significant reduction in 
the expression of both CBS protein and mRNA (P < 0.01 and 
P <  0.001 vs. uninfected, respectively; Figures  2A,B). This 
effect translated into a significant reduction of H2S levels in 
inflamed colon (Figure 2D). CSE levels were left unchanged 
(Figures 2A,B).
h2s Donor reduces colitis severity
To support the hypothesis that the reduction of H2S synthesis 
contributes to the development of Hh-induced colitis, we per-
formed a pharmacological modulation. DATS, a natural long 
lasting H2S donor (22) was orally administered to Rag2−/− mice 
previously infected with Hh (1.0 × 108 CFU). Four weeks after 
infection, a group of mice received DATS at 50  mg/kg while 
the control group received only the vehicle (PBS) every day 
for 2  weeks. Mice were analyzed for intestinal inflammation 
6  weeks after the first infection with Hh. In DATS-treated 
group, a significant (P <  0.05) reduction of colon inflamma-
tion as compared with the control group was evident. The 
histological analysis revealed that the reduction in colon 
inflammation score induced by DATS was more marked in 
the colon distal part (Figures  3A,B). The anti-inflammatory 
effect of DATS was not associated with a change in bacterial 
burden, as we could not detect any differences in cecal Hh 
colonization levels upon treatment (Figure  4). Thus, to gain 
insights into the anti-inflammatory mechanism(s) of H2S in 
this model of colitis-associated cancer, we analyzed the content 
of pro-inflammatory cytokines. As shown in Figure  5A, the 
inflammatory response was sustained by high levels of IL-6 
and TNF-α mRNA expression in colonic tissues from infected 
mice, as compared to uninfected mice. In DATS-treated 
mice, a reduction of the pro-inflammatory cytokines mRNA 
was observed confirming a key role for these cytokines. This 
hypothesis is further supported by the in  vitro experiments 
carried out on BM-derived macrophages (BMDMs) stimulated 
with Hh bacteria (20 MOI). As expected, infection of BMDMs 
cells with Hh induced a sustained release of IL-6 and TNFα 
in the supernatants as compared to unstimulated BMDM. 
Overnight incubation of infected BMDMs cells with DATS 
(10 µM) significantly (P < 0.001) reduced the release of these 
cytokines (Figure 5B).
h2s reduces the number of g-MDscs
To evaluate if the hydrogen sulfide effect on the intestinal 
inflammation was due to a modification of the innate immune 
response, we isolated and characterized colon and spleen 
leukocytes from Hh-infected mice. As expected, Hh-mediated 
FigUre 1 | Helicobacter hepaticus (Hh) infection induces myeloid-derived suppressor cells (MDSCs) accumulation. 129SvEv Rag2−/− mice were infected with 
Hh and sacrificed after 3 or 6 weeks after infection. (a) Scores of colon inflammation assessed by histological analysis. (B) Spleen weights. (c) Representative 
FACS plots showing the gating strategy used to identify MDSCs subpopulations. Following a leukocytes gate (CD45+), cells were further gated for CD11b+ 
myeloid cells. Ly6C and Ly6G were used to distinguish M-MDSCs and G-MDSCs. (D–g) Flow cytometric analysis of M-MDSCs and G-MDSCs populations as 
gated in panel (c) and relative quantification in colon (D,e) and spleen (F,g) of 129SvEv Rag2−/− uninfected or Hh-infected mice. The frequency of G-MDSCs 
and M-MDSCs significantly increased in time-dependent manner in both colon and spleen. In particular, 6 weeks post-infection, the accumulation of G-MDSCs 
was about 20- and 30-fold higher in colon and spleen, respectively, as compared to uninfected mice. On the other hand, intestinal or splenic M-MDSCs 
fraction only increased by 10% in Hh-infected mice 6 weeks post-infection. Data are shown as mean ± SEM (n = 5 per group) (**P < 0.01, ***P < 0.001 vs. 
uninfected).
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inflammation was associated with an increase in the frequency 
of both G-MDSCs and M-MDSCs cells in infected mice as com-
pared with uninfected mice. Replenishing hydrogen sulfide, by 
using as exogenous source the H2S donor DATS, induced a 
significative reduction both in the frequency (P < 0.05 vs. PBS) 
and in the absolute number (P < 0.01 vs. PBS) of G-MDSCs 
in colon (Figure 6A). It has to be noted that hydrogen sulfide 
addition did not affect G-MDSCs frequencies in the spleen 
(Figure  6B) suggesting a localized anti-inflammatory effect. 
Finally, the number of both colon and spleen M-MDSCs 
were not affected by DATS treatment (Figures 6C,D). Thus, 
the H2S-induced reduction of Hh-triggered inflammation 
is related to the modulation of the innate component of the 
immune system.
DiscUssiOn
Infiltration of immune cells, specifically CD11b+ myeloid cells, 
and their aberrant activation play a central role in carcinogenesis 
contributing to create a pro-inflammatory microenvironment 
that enables tumor promotion (23). MDSCs have emerged as 
key effector cells in tumor microenvironment responsible for 
FigUre 2 | H2S production is significantly reduced during Helicobacter hepaticus (Hh)-induced colitis. 129SvEv Rag2−/− mice were infected with Hh and sacrificed 
6 weeks post-infection. (a) Representative western blot and (B) relative CSE and CBS mRNA expression performed on colon samples from uninfected and 
Hh-infected mice. A significant reduction in the expression of both CBS protein and mRNA was observed in Hh-infected mice. (c) H2S synthesis by the colon of 
healthy mice was measured in colon homogenates, in the absence or presence of CBS inhibitor [(CHH), 3 mmol/L] or CSE inhibitor (PAG, 10 mmol/L). The substrate 
for H2S synthesis (l-cys) was present at 4 mmol/L. Only CHH significantly reduced H2S synthesis in tissue from healthy controls (***P < 0.001 vs. l-cys alone).  
(D) H2S levels measured in the colon of Hh-infected mice 3 or 6 weeks post-infection resulted significantly reduced as compared to uninfected mice. Data are 
shown as mean ± SEM (n = 5 per group) (**P < 0.01, ***P < 0.001 vs. uninfected).
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tumor progression and metastasis (24). Since pro-inflammatory 
molecules induce MDSCs, we speculate that Hh infection of 
Helicobacter-free 129SvEv/Rag2−/− mice could promote MDSC 
accumulation in colon and spleen facilitating tumor formation. 
Conflicting data are present in literature regarding MDSCs 
accumulation and function during colitis in mice. These diver-
gences are likely due to the specific experimental animal model 
used. Haile et al., using a model of T cell-mediated autoimmune 
enterocolitis, showed that MDSCs were protective and sup-
pressed development of disease (25). In another study, Zhang and 
coworkers, using a model of colitis induced by dextran sodium 
sulfate (DSS), demonstrated that the transfer of splenic DSS-
derived CD11b+Gr-1+ MDSCs into a recipient mice suppressed 
myeloid-lineage cell development in the lamina propria and 
ameliorated disease parameters (26). There is also evidence sup-
porting a pro-inflammatory role of myeloid cells in experimental 
FigUre 4 | DATS does not affect Helicobacter hepaticus (Hh) colonization 
levels. Quantification of Hh DNA in cecum content samples from healthy mice 
and from 6 weeks Hh-infected mice treated with DATS or vehicle (PBS) by 
using a real-time PCR assay. Data are shown as mean ± SEM (n = 5 per 
group).
FigUre 3 | H2S donor reduces the severity of colitis. (a) Representative photomicrographs (magnification ×50) of H&E-stained proximal, middle, and distal colon 
isolated from healthy mice and from 6 weeks Helicobacter hepaticus-infected mice treated with DATS or only vehicle (PBS) and correspondent (B) inflammation 
score. DATS significantly reduced inflammation in the colon. Data are shown as mean ± SEM (n = 5 per group) (***P < 0.001 vs. uninfected. °P < 0.05 vs. PBS).
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IBD. In fact, Guan et al. observed that both CD11b+Ly6C+ and 
CD11b+Ly6G+ cells increased in spleen and in colonic lamina 
propria in mice with acute colitis and also correlated with the 
intestinal inflammation severity (27).
Thus, to better define the role of MDSCs in colitis-
associated cancer development, we decided to use an innate 
immune-mediated IBD model lacking the adaptive immune 
response. Another benefit of the model chosen is that it closely 
resembles human IBD since members of the Helicobacteraceae 
family have been found in the colon of IBD patients (28, 29). 
The development of colitis in Hh-infected Rag2−/− mice was 
accompanied by an increase of MDSCs in lymphoid and non-
lymphoid tissue in a time-dependent manner. The G-MDSCs 
subtype was predominant both in the spleen and in the colon 
of infected mice. This finding is in accordance with the current 
relevant literature and confirms that during tumor progression 
the G-MDSC population is predominant (30). Oxidative stress in 
human IBD correlates with disease activity and represents one of 
the key features of tumor initiation (31). More recently, a role for 
hydrogen sulfide in oxidative stress has been defined (32). H2S is 
an endogenous mediator that exhibits several anti-inflammatory 
activities and contribute to gastric mucosal defense (15). Its 
protective role in the resolution of colitis and ulcer healing in 
rats and mice has been elegantly demonstrated by Wallace and 
coworkers (15, 16, 33, 34). In the attempt to better define the 
downstream signaling in this model we have assessed the pos-
sible role played by the hydrogen sulfide pathway. It is widely 
assumed that desulfhydration of l-cys is the major source of H2S 
in mammals and is catalyzed by the trans-sulfuration pathway 
enzymes: CBS and CSE. They are both P5P-dependent lyases 
and generate H2S in many tissues including brain, liver, kidney, 
ileum, uterus, and placenta. Beside other main reactions, CBS 
and CSE catalyze the synthesis of cystathionine from l-cysteine 
and l-homocysteine, generating H2S (35). In addition, a third 
pathway represented by the enzymes 3-mercaptopyruvate 
sulphurtransferase (3MST) in conjunction with cysteine ami-
notransferase, has been found to contribute to H2S production 
in the brain and in the vascular endothelium of thoracic aorta 
FigUre 5 | DATS reduces pro-inflammatory cytokines production. (a) Relative expression of TNF-α and IL-6 mRNA within the colons of both uninfected mice and 
Helicobacter hepaticus (Hh)-infected mice, 6 weeks post-infection, receiving DATS or vehicle (PBS). Expression of cytokines mRNA was determined by real-time 
quantitative PCR. Data are shown as mean ± SEM (n = 5 per group) (***P < 0.001 vs. PBS). (B) Bone marrow-derived macrophages from uninfected mice were 
stimulated with live Hh (20 MOI). Incubation of cells with DATS (10 µM) significantly reduced IL-6 and TNFα release. Data are shown as mean ± SEM of three pooled 
independent experiments (***P < 0.001 vs. Hh-infected).
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(36, 37). Finally, very recently, it has been discovered that also 
cysteinyl-tRNA synthetases 2 (CARS2), a mitochondrial isoform 
of CARS, are involved in polysulfide production (38). CBS and 
CSE are currently considered the major H2S enzymatic source in 
a variety of tissues; we therefore concentrated our attention on 
these enzymes. However, the possible contribution of the other 
alternative metabolic pathways in the development of colitis in 
Hh-infected mice cannot be completely excluded. Our results 
demonstrated that CBS is the primary H2S-producing enzyme 
in the colon of both healthy and infected Rag2−/− mice. In this 
regard, CBS in rat colon do represent the major source of colonic 
H2S either in healthy state or during inflammation (16). H2S 
synthesis by the Hh-infected mice colon was reduced by 100-fold 
after induction of colitis at 3 and 6  weeks, thereby implying a 
putative protective role for hydrogen sulfide. This reduction of 
H2S synthesis well fits with the downregulation of CBS protein 
and mRNA expression in the colon of infected mice during colitis. 
Hh-mediated inflammation induced an increase in the frequency 
of G-MDSCs and M-MDSCs cells in colon and in spleen of 
infected mice as opposite to control mice. To further investigate 
on the contribution of hydrogen sulfide, we designed an experi-
ment where the exogenous hydrogen sulfide was “furnished” by 
mean of a donor. Chronic oral administration of the H2S donor 
DATS did not cause eradication of bacteria or decreased levels 
of colonization in mice but reduced colon inflammation. It has 
to be noted that the mechanisms by which H2S is released from 
DATS have in depth analyzed by several research groups (22, 
39–42). In particular, it has been shown that H2S is liberated from 
DATS in presence of GSH and l-cys (43). However, sulfane sulfur 
(polysulfides), rather than H2S, are considered the active agent in 
physiological signaling (44–47). The recent study (38) showing 
that CBS and CARS2 can also produce sulfane sulfur species 
directly from cystine and cysteine, respectively, added another 
tassel in this already very complicated puzzle.
Finally, in order to gain mechanistic insights into this anti-
inflammatory effect, we have evaluated changes in the inflam-
matory phenotype of the immune population in the colon. 
Treatment with DATS induced a significative reduction both 
in the frequency and in the absolute number of G-MDSCs in 
colon without affecting G-MDSCs frequencies in the spleen. This 
finding implies a localized selective effect of hydrogen sulfide on 
colon G-MDSCs population.
It has been shown that Hh-induced malignancy in Rag2−/− 
mice was readily reversible by blocking underlying bacteria-
driven inflammation with antibodies directed at TNF-α and 
IL-6 (48, 49). TNF-α and IL-6 signaling has been proposed as 
FigUre 6 | DATS inhibits G-MDSCs accumulation in the colon of Helicobacter hepaticus (Hh)-infected mice. Leukocytes were isolated from the colon and the 
spleen of 129SvEv Rag2−/− uninfected or Hh-infected 6 weeks post-infection. Infected mice were treated with DATS or vehicle (PBS). G-MDSCs and M-MDSCs 
frequencies and absolute number were assessed by flow cytometry in colon (a,c) and in spleen (B,D). G-MDSCs frequency and number was reduced in the colon 
following treatment with DATS. Data are shown as mean ± SEM (n = 5 per group) (*P < 0.05, **P < 0.01, DATS vs. PBS).
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a tumor-promoting mechanism in colitis-associated cancer. In 
fact, the levels of these pro-inflammatory cytokines increase 
during inflammatory reactions and are responsible, at least in 
part, for MDSCs accumulation and for the increase in their sup-
pressive activity (24). In tune with these findings, levels of IL-6 
and TNF-α mRNA are increased in colonic tissues from infected 
mice. Interestingly, hydrogen sulfide replenishment with DATS 
reduced TNF-α and IL-6 levels as compared to control mice. To 
further support our hypothesis, we performed experiments on 
BM-derived macrophages stimulated with Hh bacteria. Indeed, 
it is known that Hh challenge of ex vivo-cultured BMDMs 
induces activation of both the NF-κB and ERK pathways 
(50, 51). Infection of BMDMs cells with Hh induced a sustained 
release of the pro-inflammatory cytokines IL-6 and TNFα in the 
supernatants as compared to unstimulated BMDM. Treatment 
of BMDMs cells with exogenous hydrogen sulfide, by using 
DATS, reduced cytokines release mimicking the in vivo setting. 
In conclusion, these results indicate that the metabolic pathway 
l-cys/H2S can exert a protective role in intestinal Hh-induced 
inflammation. Dysregulation of H2S homeostasis has also been 
implicated in numerous pathological conditions and diseases 
(52). Thus, the reduction of H2S levels reported during colitis 
might induce metabolic changes in the microenvironment, as 
the alteration of the redox cellular status, which promotes tumo-
rigenesis. Metabolic reprograming has been suggested as a key 
hallmark of cancer progression (53). Recent studies have revealed 
that immune cells possess distinct metabolic characteristics that 
influence their immunological phenotype and functions and so 
their contribution to cancer progression (54). Thus, the identi-
fication of new metabolic targets could be of great importance 
in modifying the plasticity of tumor-promoting immune cells 
and in CRC prevention. Our results demonstrating that MDSCs 
mediate significant intestinal inflammation upon stimulation 
with pathogenic Hh assume a therapeutic significance since, 
targeting MDSCs would be promising treatment option for IBD 
patient to reduce the risk of CRC and to manage inflammatory 
symptoms in order to provide an improved quality of life.
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